RecruitingNCT06837181
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Studying Cystic fibrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Jaeb Center for Health Research
- Intervention
- observational study(other)
- Enrollment
- 200 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2025 – 2028
Study locations (18)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Keck Medical Center of USC, Los Angeles, California, United States
- Stanford University, Palo Alto, California, United States
- University of California San Diego, San Diego, California, United States
- University of Colorado Denver, Aurora, Colorado, United States
- University of Miami, Miami, Florida, United States
- Emory University School of Medicine, Atlanta, Georgia, United States
- University of Iowa, Iowa City, Iowa, United States
- Tulane University, New Orleans, Louisiana, United States
- Massachusetts, Boston, Massachusetts, United States
- University of Minnesota, Minneapolis, Minnesota, United States
- University of New Mexico, Albuquerque, New Mexico, United States
- Columbia University Cystic Fibrosis Program, New York, New York, United States
- Atrium Health Wake Forest Baptist (Wake Forest Baptist), Winston-Salem, North Carolina, United States
- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- +3 more locations on ClinicalTrials.gov
Collaborators
Cystic Fibrosis Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06837181 on ClinicalTrials.govOther trials for Cystic fibrosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07437105Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNANCT07436351ACT With CF Self-Help ToolkitThomas Jefferson University
- RECRUITINGNANCT07314229Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-IvacaftorUniversity Hospital, Lille
- RECRUITINGNCT07083557Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)Bettina Mittendorfer
- RECRUITINGNCT07369414Environmental Reservoirs of Non-tuberculous Mycobacteria in Cystic Fibrosis Households: A Case-control Study of Exposure Risk at HomeResearch Center Borstel
- RECRUITINGNCT07505797ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE)iSono Health, Inc.
- RECRUITINGPHASE1NCT07283770Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-581 in Healthy ParticipantsVertex Pharmaceuticals Incorporated
- RECRUITINGNCT07363304Impact of Elexacaftor-Tezacaftor-Ivacaftor Treatment on Metabolic, Epigenetic and Fecal Microbiota Profiles in People With Cystic Fibrosis.Meyer Children's Hospital IRCCS